Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company
developing personalized immunotherapies including multiple sclerosis
(MS) and neuromyelitis optica (NMO), today reported financial results
for the year ended December 31, 2014 and provided an update on the
Company’s recent corporate developments.
Ophthotech Corporation (Nasdaq:OPHT) today announced financial results
for the fourth quarter and full year ended December 31, 2014 and
provided an update on the Company’s business and product development
By Inti Landauro
PARIS--French telecom giant Orange SA (ORA.FR) on Monday said it has agreed to buy the stake held by Orascom Telecom (OTMT.CI) in Egyptian Company for Mobile Services (EMOB.CI), which operates the mobile phone network Mobinil, for an overall amount of 210 million euros ($237 million).
With the transaction, Orange will raise its stake in the Egyptian unit to 99% from 94%.
The operation, which is expected to be concluded by the end of the first quarter, is part of an agreement sealed by Orange and Orascom in April 2012.
ORBCOMM Inc. (Nasdaq:ORBC), a global provider of Machine-to-Machine
(M2M) solutions, today announced that its senior management will be
presenting at the 36 th Annual Raymond James Institutional
Investors Conference at the JW Marriott Grande Lakes in Orlando,
Orbital ATK (NYSE: OA), a global leader in aerospace and defense
technologies, completed the installation and integration of its AAR-47
Missile and Laser Warning System with Hostile Fire Indication (HFI),
Symetrics’ ALE-47 Countermeasures Dispensing System (CMDS), and
Southeast Aerospace’s aircraft modification kits onto AH-1S helicopters
for the Republic of Korea Army.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.